Skip to main content
Journal cover image

Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.

Publication ,  Journal Article
Leuchter, AF; Cook, IA; Feifel, D; Goethe, JW; Husain, M; Carpenter, LL; Thase, ME; Krystal, AD; Philip, NS; Bhati, MT; Burke, WJ; Howland, RH ...
Published in: Brain Stimul
2015

BACKGROUND: Transcranial Magnetic Stimulation (TMS) customarily uses high-field electromagnets to achieve therapeutic efficacy in Major Depressive Disorder (MDD). Low-field magnetic stimulation also may be useful for treatment of MDD, with fewer treatment-emergent adverse events. OBJECTIVE/HYPOTHESIS: To examine efficacy, safety, and tolerability of low-field magnetic stimulation synchronized to an individual's alpha frequency (IAF) (synchronized TMS, or sTMS) for treatment of MDD. METHODS: Six-week double-blind sham-controlled treatment trial of a novel device that used three rotating neodymium magnets to deliver sTMS treatment. IAF was determined from a single-channel EEG prior to first treatment. Subjects had baseline 17-item Hamilton Depression Rating Scale (HamD17) ≥ 17. RESULTS: 202 subjects comprised the intent-to-treat (ITT) sample, and 120 subjects completed treatment per-protocol (PP). There was no difference in efficacy between active and sham in the ITT sample. Subjects in the PP sample (N = 59), however, had significantly greater mean decrease in HamD17 than sham (N = 60) (-9.00 vs. -6.56, P = 0.033). PP subjects with a history of poor response or intolerance to medication showed greater improvement with sTMS than did treatment-naïve subjects (-8.58 vs. -4.25, P = 0.017). Efficacy in the PP sample reflects exclusion of subjects who received fewer than 80% of scheduled treatments or were inadvertently treated at the incorrect IAF; these subgroups failed to separate from sham. There was no difference in adverse events between sTMS and sham, and no serious adverse events attributable to sTMS. CONCLUSIONS: Results suggest that sTMS may be effective, safe, and well tolerated for treating MDD when administered as intended.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Brain Stimul

DOI

EISSN

1876-4754

Publication Date

2015

Volume

8

Issue

4

Start / End Page

787 / 794

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transcranial Magnetic Stimulation
  • Psychiatric Status Rating Scales
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Humans
  • Female
  • Double-Blind Method
  • Depressive Disorder, Major
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Leuchter, A. F., Cook, I. A., Feifel, D., Goethe, J. W., Husain, M., Carpenter, L. L., … George, M. S. (2015). Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul, 8(4), 787–794. https://doi.org/10.1016/j.brs.2015.05.005
Leuchter, Andrew F., Ian A. Cook, David Feifel, John W. Goethe, Mustafa Husain, Linda L. Carpenter, Michael E. Thase, et al. “Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.Brain Stimul 8, no. 4 (2015): 787–94. https://doi.org/10.1016/j.brs.2015.05.005.
Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, et al. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul. 2015;8(4):787–94.
Leuchter, Andrew F., et al. “Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.Brain Stimul, vol. 8, no. 4, 2015, pp. 787–94. Pubmed, doi:10.1016/j.brs.2015.05.005.
Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O’Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul. 2015;8(4):787–794.
Journal cover image

Published In

Brain Stimul

DOI

EISSN

1876-4754

Publication Date

2015

Volume

8

Issue

4

Start / End Page

787 / 794

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transcranial Magnetic Stimulation
  • Psychiatric Status Rating Scales
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Humans
  • Female
  • Double-Blind Method
  • Depressive Disorder, Major